GLP-1
GLP-1 is a pharmaceutical drug with 33 clinical trials. Currently 4 active trials ongoing. Historical success rate of 95.0%.
Success Metrics
Based on 19 completed trials
Phase Distribution
Phase Distribution
6
Early Stage
2
Mid Stage
1
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
86.4%
19 of 22 finished
13.6%
3 ended early
4
trials recruiting
33
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
The Effect of GIP, GLP-1 and GLP-2 in Individuals With Genetically Altered Receptor Function
People With Multiple Sclerosis Treated With Ocrelizumab and GLP-1 Agonists
Insulin-Mediated Glucose Uptake and Organ Perfusion Assessed by Total-Body PET During GIP and GLP-1 Infusion
GLP-1 Medicines and Mental Health Changes
Beta-cell Response to Incretin Hormones in Cystic Fibrosis
Clinical Trials (33)
The Effect of GIP, GLP-1 and GLP-2 in Individuals With Genetically Altered Receptor Function
People With Multiple Sclerosis Treated With Ocrelizumab and GLP-1 Agonists
Insulin-Mediated Glucose Uptake and Organ Perfusion Assessed by Total-Body PET During GIP and GLP-1 Infusion
GLP-1 Medicines and Mental Health Changes
Beta-cell Response to Incretin Hormones in Cystic Fibrosis
Behavioral Therapy and GLP-1 Analogue Effects on Binge Eating, Weight, and Coping in Obesity
Effectiveness of Microdosed GLP-1 in Improving Health, Quality of Life, and Longevity Measures
Comparative Cardiovascular Effectiveness of GLP-1 RAs vs. Insulin in Early-Onset Type 2 Diabetes
Effect of GLP-1 on Microvascular Insulin Responses in Type 1 Diabetes
Splanchnic Blood Redistribution After Incretin Hormone Infusion and Obesity Surgery
Effect of GIP After a Meal in Patients With Type 2 Diabetes
GLP-1 Inhibits Prandial Antro-duodeno-jejunal Motility in Humans
To Determine the Effect of GLP1 on Cognitive Function, Brain Glucose Metabolism and Neuroplasticity.
GLP-1 Loading During Elective Percutaneous Coronary Intervention
Characterizing the Incretin Effect of Amino Acids and Defining GLP-1 Role on Skeletal Muscle
The Effect of Surgically Induced Weight Loss on Endocrine Function, Cardiovascular Function and Body Composition
Glucose-Dependent Insulinotropic Polypeptide - Effects on Markers of Bone Turnover in Patients With Type 1 Diabetes
The Microvascular Function of GLP-1 and Its Analogues
Incretin Regulation of Insulin Secretion in Monogenic Diabetes
Effects of GLP-1 on Chronic Heart Failure
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 33